This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Ackman vs. Herbalife: HLF Spends 10x in Washington Lobbying

NEW YORK (TheStreet) -- If lawmakers in Washington may ultimately decide the fate of Herbalife (HLF - Get Report), hedge-funder Bill Ackman of Pershing Square Capital Management might want to throw a few more lobbying dollars behind a short trade that once stood at about $1 billion.

A review of publicly disclosed political campaign donations indicates that Herbalife spent about 10 times the amount that Pershing Square did in Washington in 2013. A mid-term election year in Congressional, Senatorial and gubernatorial races across the country, however, could create a new battlefield for Herbalife and Ackman in 2014.

The notion that Ackman's fight against Herbalife may be resolved in Washington was underscored last week when Sen. Edward J. Markey (D., Mass.) asked that the Securities and Exchange Commission and Federal Trade Commission seek more information into Herbalife's business practices. A day later, the League of United Latin American Citizens applauded Markey's probe.

Both announcements sent Herbalife shares tumbling to six-month lows, however, the company's stock remains well above its trading prices prior to Ackman's disclosure of his short in late December 2012.

Must Read: The State of the Union and a Winning GOP Strategy

A Jan. 23 letter from Markey to Herbalife asked that the company detail the percentage of revenue it earns from customers outside its multi-level distributing network, echoing a similar line of questioning from Ackman and Pershing Square. The Senator also queried for details on the amount of profit the average distributor might make on out-of-network sales.

Markey's questions appear to be aimed at judging whether or not Herbalife is a so-called pyramid scheme, a characterization the company has vehemently denied. His entrance into the debate, meanwhile, re-ignited speculation that political influencing could ultimately decide one of the most controversial trades in the history of the hedge fund industry. 

Were that to be the case, Ackman and Pershing Square are far behind Herbalife in direct campaign spending and lobbying, even as the hedge funder has publicly said his short trade could come down to whether or not the FTC or SEC decides to take up his claims. Publicly disclosed spending figures also show that while Herbalife has increased spending efforts in 2013, Ackman may just be figuring out how to play the Washington game.

In 2013, Pershing Square began lobbying in Washington, spending $90,000.00 with the Wexler & Walker Public Policy Association and $48,000.00 with the Moffett Group, a lobbyist that Politico reported worked to gain signatures on a letter Rep. Linda Sanchez (D-Calif.) sent to the FTC to investigate Herbalife's business practices. Pershing's lobbyists targeted signatures from the Congressional Hispanic Caucus (CHC), according to Politico's reporting. Prior to 2013, Pershing Square hadn't conducted lobbying in Washington.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
HLF $57.95 0.00%
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs